JP2022553406A5 - - Google Patents
Info
- Publication number
- JP2022553406A5 JP2022553406A5 JP2022524118A JP2022524118A JP2022553406A5 JP 2022553406 A5 JP2022553406 A5 JP 2022553406A5 JP 2022524118 A JP2022524118 A JP 2022524118A JP 2022524118 A JP2022524118 A JP 2022524118A JP 2022553406 A5 JP2022553406 A5 JP 2022553406A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- expression cassette
- nucleotides
- seq
- raav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924970P | 2019-10-23 | 2019-10-23 | |
| US62/924,970 | 2019-10-23 | ||
| US201962934915P | 2019-11-13 | 2019-11-13 | |
| US62/934,915 | 2019-11-13 | ||
| USPCT/US2019/067872 | 2019-12-20 | ||
| PCT/US2019/067872 WO2020132455A1 (en) | 2018-12-21 | 2019-12-20 | Compositions for drg-specific reduction of transgene expression |
| US202062972404P | 2020-02-10 | 2020-02-10 | |
| US62/972,404 | 2020-02-10 | ||
| US202063005894P | 2020-04-06 | 2020-04-06 | |
| US63/005,894 | 2020-04-06 | ||
| US202063023602P | 2020-05-12 | 2020-05-12 | |
| US63/023,602 | 2020-05-12 | ||
| US202063038514P | 2020-06-12 | 2020-06-12 | |
| US63/038,514 | 2020-06-12 | ||
| US202063043600P | 2020-06-24 | 2020-06-24 | |
| US63/043,600 | 2020-06-24 | ||
| PCT/US2020/056881 WO2021081217A1 (en) | 2019-10-23 | 2020-10-22 | Compositions for drg-specific reduction of transgene expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553406A JP2022553406A (ja) | 2022-12-22 |
| JP2022553406A5 true JP2022553406A5 (cg-RX-API-DMAC7.html) | 2023-10-18 |
| JP7697943B2 JP7697943B2 (ja) | 2025-06-24 |
Family
ID=75620360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022524118A Active JP7697943B2 (ja) | 2019-10-23 | 2020-10-22 | 導入遺伝子発現のdrg特異的低減のための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220389457A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048785A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7697943B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220105158A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020369570A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3155154A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL292372A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021081217A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298138A (en) * | 2020-05-12 | 2023-01-01 | Univ Pennsylvania | Compositions for drg-specific reduction of transgene expression |
| US20230372539A1 (en) * | 2020-08-24 | 2023-11-23 | The Trustees Of The University Of Pennsylvania | Viral vectors encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases |
| KR20240100490A (ko) * | 2021-10-18 | 2024-07-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Cdkl5 결핍 장애(cdd)의 치료에 유용한 조성물 |
| AU2022379625A1 (en) * | 2021-10-27 | 2024-05-16 | The University Of North Carolina At Chapel Hill | Aav-idua vector for treatment of mps i |
| US20260000790A1 (en) * | 2022-07-08 | 2026-01-01 | Ospedale San Raffaele S.R.L. | Transgene cassettes |
| CN116064593B (zh) * | 2023-02-09 | 2024-05-14 | 四川大学 | 一种毛白杨pgag基因及其应用 |
| WO2025188755A1 (en) * | 2024-03-04 | 2025-09-12 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| FR3004463A1 (fr) * | 2013-04-11 | 2014-10-17 | Genethon | Systeme d'expression pour une therapie genique selective |
| LT3137497T (lt) * | 2014-05-02 | 2021-07-26 | Genzyme Corporation | Aav vektoriai, skirti tinklainės ir cns genų terapijai |
| KR20220082100A (ko) * | 2015-05-15 | 2022-06-16 | 리젠츠 오브 더 유니버시티 오브 미네소타 | 중추 신경계로의 아데노-연관 치료적 전달 |
| MA43968A (fr) * | 2016-02-03 | 2018-12-12 | Univ Pennsylvania | Thérapie génique pour traiter la mucopolysaccharidose de type i |
| CN108697774A (zh) * | 2016-02-22 | 2018-10-23 | 北卡罗来纳大学教堂山分校 | 治疗mps i-相关失明的aav-idua载体 |
| CA3068328A1 (en) * | 2017-07-06 | 2019-01-10 | The Trustees Of The University Of Pennsylvania | Aav9-mediated gene therapy for treating mucopolysaccharidosis type i |
| DK3684423T5 (da) * | 2017-09-20 | 2024-08-26 | 4D Molecular Therapeutics Inc | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf |
-
2020
- 2020-10-22 JP JP2022524118A patent/JP7697943B2/ja active Active
- 2020-10-22 CA CA3155154A patent/CA3155154A1/en active Pending
- 2020-10-22 AU AU2020369570A patent/AU2020369570A1/en active Pending
- 2020-10-22 EP EP20880317.1A patent/EP4048785A4/en active Pending
- 2020-10-22 IL IL292372A patent/IL292372A/en unknown
- 2020-10-22 US US17/770,137 patent/US20220389457A1/en active Pending
- 2020-10-22 WO PCT/US2020/056881 patent/WO2021081217A1/en not_active Ceased
- 2020-10-22 KR KR1020227016895A patent/KR20220105158A/ko active Pending